Kp Tissue PT Lowered to C$20.00 (KPT)
Equities researchers at RBC Capital reduced their price target on shares of Kp Tissue (TSE:KPT) from C$21.00 to C$20.00 in a research report issued on Monday, Stock Ratings Network reports. The firm currently has an “outperform” rating on the stock. RBC Capital’s price target points to a potential upside of 16.01% from the company’s current price.
Shares of Kp Tissue (TSE:KPT) traded down 0.52% on Monday, hitting $17.15. The stock had a trading volume of 2,579 shares. Kp Tissue has a 1-year low of $16.20 and a 1-year high of $19.75. The stock has a 50-day moving average of $17.24 and a 200-day moving average of $17.60.
KP Tissue Inc is created to acquire, and its business will be limited to holding, a limited partnership interest in Kruger Products L.
Get Analysts' Upgrades and Downgrades via Email - Stay on top of analysts' coverage with Analyst Ratings Network's FREE daily email newsletter that provides a concise list of analysts' upgrades and downgrades. Click here to register now.